These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16286161)

  • 1. High-density lipoprotein function recent advances.
    Ansell BJ; Watson KE; Fogelman AM; Navab M; Fonarow GC
    J Am Coll Cardiol; 2005 Nov; 46(10):1792-8. PubMed ID: 16286161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL function as a target of lipid-modifying therapy.
    Watson KE; Ansell BJ; Watson AD; Fonarow GC
    Rev Cardiovasc Med; 2007; 8(1):1-8. PubMed ID: 17401296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The paradox of dysfunctional high-density lipoprotein.
    Ansell BJ; Fonarow GC; Fogelman AM
    Curr Opin Lipidol; 2007 Aug; 18(4):427-34. PubMed ID: 17620860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the anti-inflammatory effects of high-density lipoprotein.
    Ansell BJ
    Am J Cardiol; 2007 Dec; 100(11 A):n3-9. PubMed ID: 18047850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.
    Kontush A; Chapman MJ
    Pharmacol Rev; 2006 Sep; 58(3):342-74. PubMed ID: 16968945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease.
    Vaziri ND
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S35-43. PubMed ID: 20797569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current understanding of the role of high-density lipoproteins in atherosclerosis and senescence.
    Nofer JR; Walter M; Assmann G
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1071-86. PubMed ID: 16292998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoproteins, inflammation and oxidative stress.
    Tabet F; Rye KA
    Clin Sci (Lond); 2009 Jan; 116(2):87-98. PubMed ID: 19076062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple actions of high-density lipoprotein.
    Florentin M; Liberopoulos EN; Wierzbicki AS; Mikhailidis DP
    Curr Opin Cardiol; 2008 Jul; 23(4):370-8. PubMed ID: 18520722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density lipoprotein metabolism and endothelial function.
    Lowenstein CJ; Cameron SJ
    Curr Opin Endocrinol Diabetes Obes; 2010 Apr; 17(2):166-70. PubMed ID: 20125006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiinflammatory properties of HDL.
    Barter PJ; Nicholls S; Rye KA; Anantharamaiah GM; Navab M; Fogelman AM
    Circ Res; 2004 Oct; 95(8):764-72. PubMed ID: 15486323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
    McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
    Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.
    Patel S; Drew BG; Nakhla S; Duffy SJ; Murphy AJ; Barter PJ; Rye KA; Chin-Dusting J; Hoang A; Sviridov D; Celermajer DS; Kingwell BA
    J Am Coll Cardiol; 2009 Mar; 53(11):962-71. PubMed ID: 19281927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density lipoprotein: a potent inhibitor of inflammation.
    Murphy AJ; Woollard KJ
    Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):710-8. PubMed ID: 19930423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins.
    Malle E; Marsche G; Panzenboeck U; Sattler W
    Arch Biochem Biophys; 2006 Jan; 445(2):245-55. PubMed ID: 16171772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the concentration and antiatherogenic activity of high-density lipoproteins.
    Barter PJ; Rye KA
    Curr Opin Lipidol; 2006 Aug; 17(4):399-403. PubMed ID: 16832163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation, high-density lipoprotein and cardiovascular dysfunction.
    Haas MJ; Mooradian AD
    Curr Opin Infect Dis; 2011 Jun; 24(3):265-72. PubMed ID: 21326098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The double jeopardy of HDL.
    Navab M; Ananthramaiah GM; Reddy ST; Van Lenten BJ; Ansell BJ; Hama S; Hough G; Bachini E; Grijalva VR; Wagner AC; Shaposhnik Z; Fogelman AM
    Ann Med; 2005; 37(3):173-8. PubMed ID: 16019715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is raising HDL a futile strategy for atheroprotection?
    Joy T; Hegele RA
    Nat Rev Drug Discov; 2008 Feb; 7(2):143-55. PubMed ID: 18239670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.